Road to a New Study from Post-hoc Findings: a Bayesian Approach
*Chul Ahn, U.S. Food and Drug Administration *Yunling Xu, CBER/FDA Keywords: Post-hoc findings, New study, Bayesian approach In this presentation, unplanned subgroup analysis will be discussed within the context of using the result to initiate a new confirmatory study. A Bayesian approach is then used to integrate the subgroup data with the new confirmatory study data to increase the overall power of the study. Some statistical issues related to such study design and analysis of the study data, including simulation of operating characteristics and assessment of exchangeability between the subgroup and the new study, will be discussed from a regulatory perspective.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC